FNDC5 and metabolic disease: AE has been suggested as an effective strategy for managing obesity and related metabolic disorders through varied mechanisms, including the upregulation of antioxidant enzymes and the release of myokines, such as irisin, that facilitate crosstalk between skeletal muscle and adipose tissue [9].